PLEASANTON, Calif., June 5, 2017 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for the cobas® CMV (cytomegalovirus) test for use on the fully ...
- CMV is the most common and serious viral infection in transplant patients - The cobas® CMV test provides reliable, reproducible, high-quality results for clinical decision-making - CMV viral load ...
April 14, 2010 — Screening newborns for cytomegalovirus (CMV) infection with real-time polymerase chain reaction (PCR) assays on dried blood spots (DBS) may have limited value, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results